| Financial Year |
March 31 2023 |
| Monetary Funds |
3,520,870,484.68 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
130,264,461.82 |
| Advances to Suppliers |
165,455,351.77 |
| Other Receivables |
40,105,357.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
601,770,220.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
44,969,413.93 |
| Total Current Assets |
4,506,222,614.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
133,775,260.61 |
| Investment Properties |
66,997,150.63 |
| Fixed Assetes |
558,845,620.89 |
| Under-construction Projects |
237,679,319.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
415,898,787.75 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,335,139.57 |
| Deferred Income Tax Assets |
61,696,773.57 |
| Other Non-Current Assets |
5,409,947.29 |
| Sub-Total of Non-Current Assets |
1,649,932,166.77 |
| Total Assets |
6,156,154,781.38 |
| Short-Term Loans |
200,195,890.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
73,238,168.12 |
| Accounts Payable |
646,031,687.27 |
| Accounts Received In Advance |
320,390.05 |
| Employee Compensation Payable |
66,930,390.39 |
| Taxes Payable |
170,946,750.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
223,414,478.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,546,904.84 |
| Other Current Liabilities |
10,910,746.59 |
| Sub-Total of Current Liabilities |
1,592,072,380.96 |
| Long-term Loans |
-- |
| Bonds Payable |
732,523,152.82 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
16,161,718.09 |
| Deferred Income Tax Liabilities |
18,771,920.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
776,506,335.22 |
| Total Liabilities |
2,368,578,716.18 |
| Paid-In Capital(Or Share Stock) |
283,520,262.00 |
| Capital Surplus |
943,231,816.87 |
| Surplus Reserve |
141,756,976.00 |
| LESS:Treasury Stock |
164,976,000.00 |
| Undistributed Profits |
2,508,420,353.69 |
| Minority Stockholder's Interest |
26,341,283.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,761,234,781.67 |
| Owner's Equity（Stockholder's Equity） |
3,787,576,065.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,156,154,781.38 |
